GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Monivent AB (XSAT:MONI) » Definitions » COGS-to-Revenue

Monivent AB (XSAT:MONI) COGS-to-Revenue : 0.26 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Monivent AB COGS-to-Revenue?

Monivent AB's Cost of Goods Sold for the three months ended in Mar. 2024 was kr0.12 Mil. Its Revenue for the three months ended in Mar. 2024 was kr0.46 Mil.

Monivent AB's COGS to Revenue for the three months ended in Mar. 2024 was 0.26.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Monivent AB's Gross Margin % for the three months ended in Mar. 2024 was 74.35%.


Monivent AB COGS-to-Revenue Historical Data

The historical data trend for Monivent AB's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Monivent AB COGS-to-Revenue Chart

Monivent AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
COGS-to-Revenue
Get a 7-Day Free Trial -11.06 -35.03 -1.53 0.59 0.41

Monivent AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.45 0.46 0.55 0.34 0.26

Monivent AB COGS-to-Revenue Calculation

Monivent AB's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=1.451 / 3.562
=0.41

Monivent AB's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.118 / 0.46
=0.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Monivent AB  (XSAT:MONI) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Monivent AB's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0.118 / 0.46
=74.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Monivent AB COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Monivent AB's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Monivent AB (XSAT:MONI) Business Description

Traded in Other Exchanges
N/A
Address
Regnbagsgatan 8B, Gothenburg, SWE, SE-417 55
Monivent AB is a medtech company focused on improving the care given to newborn babies in need of respiratory support at birth. The company has developed a patented solution that provides continuous feedback on the volumes of air given to the newborn during manual ventilation. The airflow is measured directly in the face mask and feedback on the ventilation parameters is displayed numerically and graphically in real-time on the external monitor. The company's product is Monivent Neo100.